tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EUDA Health Secures Global Rights for New Immune Supplement

Story Highlights
  • EUDA Health Holdings has secured exclusive distribution rights for a new immune health supplement.
  • The supplement will enhance EUDA’s wellness portfolio and is projected to sell 500,000 bottles in 12 months.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EUDA Health Secures Global Rights for New Immune Supplement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from EUDA Health Holdings ( (EUDA) ).

On August 26, 2025, EUDA Health Holdings Limited announced that its subsidiary, EUDA Health Pte. Ltd., has secured exclusive worldwide distribution rights for a next-generation immune health supplement from Chemokine Pte. Ltd. This supplement, marketed under the brand name Euda Helixé, will initially be available in Singapore, Malaysia, and China, with plans for future market expansion. The supplement utilizes cutting-edge epigenetic technology to enhance metabolism, boost vitality, and support longevity, reinforcing EUDA’s wellness product portfolio. This strategic move positions EUDA at the forefront of molecular precision wellness, leveraging breakthrough gene activation technology, and is expected to diversify revenue streams with projected sales of 500,000 bottles over the next 12 months.

The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.

More about EUDA Health Holdings

EUDA Health Holdings Limited is a Singapore-based leading non-invasive healthcare provider in Asia, focusing on markets in Singapore, Malaysia, and China. The company aims to become a market leader in non-invasive and preventive healthcare, particularly in the fast-growing longevity sector, addressing the healthcare needs of over 1.8 billion people in the region. EUDA also operates a property management business in Singapore.

Average Trading Volume: 76,792

Technical Sentiment Signal: Sell

Current Market Cap: $99.21M

For detailed information about EUDA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1